The Company is a provider of insurance and other financial services with operations throughout the United States and the regions of Latin America, Europe, and Asia Pacific.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I am going to go out on a limb here and put a hex, a pox and a dead chicken voodoo curse on the impending purchase of ALICO by Met. I have a feeling Met is going to majorly overpay for ALICO and will struggle mightily in integrating such a huge life insurance business. Life insurance is also a heavily commoditized product and will eventually lead to margin pressures for Met, especially if they have to borrow big money to complete this purchase. I also do not underestimate the federal government’s ability to somehow get their fingers into this deal and make it into one big mess which would send Met Life’s stock price into the toilet. Met should focus on raising their credit agency ratings, and strengthening their balance sheet before pursuing these types of M&A deals. In summary, Met should be running away from this deal screaming like a frightened little girl.